Evidence map›Paper›PMID 39907785›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Enhanced anticancer efficacy of aluminum-curcumin complex compared to curcumin in colorectal cancer cells.

Narges Jabbari, Abdolreza Sabokrouh

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Narges JabbariDepartment of Biochemistry and Biophysics, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Abdolreza SabokrouhDepartment of Biochemistry, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. sabokrouh22@gmail.com.ORCID 0000-0003-2118-6142

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evaluation of anti cancer treatments involves various methods, one of which is the use of biomarkers for therapeutic strategy. This study aimed to compare the anticancer effects of Aluminum curcumin (ACC) with curcumin (CC) in human CRC cells. In this study, the cells were classified into four groups: Group A as control cells, Group B included untreated CRC cells, and Groups C and D comprised cancer cells treated with CC and ACC, respectively. After determining the IC

Indexed as

AluminumAntineoplastic AgentsColorectal NeoplasmsCurcuminApoptosisCell Line, TumorCell SurvivalGene Expression Regulation, NeoplasticHumansMicroRNAsAluminumAntineoplastic AgentsCurcuminMicroRNAsBAXBcl-2FASLGmiRNAsTelomerase

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.